Blog

Burgess Introduces Drug Pricing Transparency Resolution
Posted by on August 8, 2019 | comments
f t # e

Washington, D.C. —Congressman Michael C. Burgess, M.D. (R-TX), Republican Leader of the Energy and Commerce Subcommittee on Health, recently introduced H.Con.Res. 55, which emphasizes the need to provide American consumers with pricing information in direct-to-consumer (DTC) television advertisements for prescription drugs.

“American patients should be informed consumers,” said Dr. Burgess. “Direct-to-consumer advertisements can provide an opportunity for Americans to understand the true cost of their prescription drugs. The Trump Administration has taken steps to make drug pricing information available in DTC advertisements. I am committed to working alongside President Trump to ensure continued transparency in these advertisements, which are prevalent in Americans’ everyday television consumption.”

Background: 
Dr. Burgess introduced a similar resolution, H.Con.Res. 146, in December 2018. For additional information, please see the full text of H.Con.Res. 55.

###

f t # e